Similar articles

• [Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].

  Ehrly AM, Breddin K. Ehrly AM, et al. Verh Dtsch Ges Kreislaufforsch. 1974;40:243-5. Verh Dtsch Ges Kreislaufforsch. 1974. PMID: 4450660 German. No abstract available.
• [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].

  Rosendo A, Sala Planell E, Latorre J, Marinello J, Olba L, Rutllant ML. Rosendo A, et al. Rev Clin Esp. 1982 Mar 15;164(5):313-6. Rev Clin Esp. 1982. PMID: 7100546 Spanish. No abstract available.
• [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].

  Artale F, Sergio G, Cramarossa L, Giunti P, Francisci A, Perego MA. Artale F, et al. Ric Clin Lab. 1983;13 Suppl 3:411-5. Ric Clin Lab. 1983. PMID: 6673022 Italian.
• [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].

  Sternitzky R, Seige K. Sternitzky R, et al. Z Gesamte Inn Med. 1983 Jan 1;38(1):1-7. Z Gesamte Inn Med. 1983. PMID: 6342278 Review. German.
• [Hemorrheology, microcirculation and oxygenation. Physiopathological and therapeutic aspects].

  Ehrly M. Ehrly M. Rev Fr Gynecol Obstet. 1991 Feb 25;86(2 Pt 2):131-8. Rev Fr Gynecol Obstet. 1991. PMID: 1767162 Review. French.